> top > docs > PMC:7536950 > spans > 104-6833 > annotations

PMC:7536950 / 104-6833 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 734-738 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T2 798-821 Body_part denotes hematopoietic stem cell http://purl.org/sig/ont/fma/fma86475
T3 817-821 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T4 949-961 Body_part denotes T‐lymphocyte http://purl.org/sig/ont/fma/fma62870
T5 1760-1770 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T6 2118-2132 Body_part denotes cranial nerves http://purl.org/sig/ont/fma/fma63820
T7 2170-2174 Body_part denotes limb http://purl.org/sig/ont/fma/fma7182
T8 2379-2392 Body_part denotes facial nerves http://purl.org/sig/ont/fma/fma50868
T9 2408-2430 Body_part denotes left hypoglossal nerve http://purl.org/sig/ont/fma/fma50903
T10 2540-2559 Body_part denotes Cerebrospinal fluid http://purl.org/sig/ont/fma/fma20935
T11 2561-2564 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T12 2633-2640 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T13 2687-2694 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T14 2705-2722 Body_part denotes white blood cells http://purl.org/sig/ont/fma/fma62852
T15 2717-2722 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T16 2754-2757 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T17 2993-2996 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T18 3088-3095 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T19 3183-3188 Body_part denotes brain http://purl.org/sig/ont/fma/fma50801
T20 3245-3259 Body_part denotes Cranial nerves http://purl.org/sig/ont/fma/fma63820
T21 3332-3349 Body_part denotes hypoglossal nerve http://purl.org/sig/ont/fma/fma50871
T22 3403-3416 Body_part denotes facial nerves http://purl.org/sig/ont/fma/fma50868
T23 3443-3457 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T24 3695-3700 Body_part denotes Chest http://purl.org/sig/ont/fma/fma9576
T25 3865-3870 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T26 3879-3882 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T27 4217-4231 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T28 4893-4909 Body_part denotes peripheral nerve http://purl.org/sig/ont/fma/fma65239
T29 5296-5322 Body_part denotes peripheral nervous systems http://purl.org/sig/ont/fma/fma9903
T30 5538-5541 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T31 5818-5822 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T32 6023-6039 Body_part denotes peripheral nerve http://purl.org/sig/ont/fma/fma65239
T33 6360-6373 Body_part denotes Cranial nerve http://purl.org/sig/ont/fma/fma5865

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 2118-2132 Body_part denotes cranial nerves http://purl.obolibrary.org/obo/UBERON_0001785
T2 2170-2174 Body_part denotes limb http://purl.obolibrary.org/obo/UBERON_0002101
T3 2379-2392 Body_part denotes facial nerves http://purl.obolibrary.org/obo/UBERON_0001647
T4 2413-2430 Body_part denotes hypoglossal nerve http://purl.obolibrary.org/obo/UBERON_0001650
T5 2425-2430 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T6 2540-2559 Body_part denotes Cerebrospinal fluid http://purl.obolibrary.org/obo/UBERON_0001359
T7 2711-2716 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T8 3183-3188 Body_part denotes brain http://purl.obolibrary.org/obo/UBERON_0000955
T9 3245-3259 Body_part denotes Cranial nerves http://purl.obolibrary.org/obo/UBERON_0001785
T10 3332-3349 Body_part denotes hypoglossal nerve http://purl.obolibrary.org/obo/UBERON_0001650
T11 3344-3349 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T12 3403-3416 Body_part denotes facial nerves http://purl.obolibrary.org/obo/UBERON_0001647
T13 3695-3700 Body_part denotes Chest http://purl.obolibrary.org/obo/UBERON_0001443
T14 3865-3870 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T15 4904-4909 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T16 5296-5322 Body_part denotes peripheral nervous systems http://purl.obolibrary.org/obo/UBERON_0000010
T17 6034-6039 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T18 6360-6373 Body_part denotes Cranial nerve http://purl.obolibrary.org/obo/UBERON_0001785
T19 6368-6373 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 15-39 Disease denotes Coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T4 41-49 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 172-187 Disease denotes viral pneumonia http://purl.obolibrary.org/obo/MONDO_0006012
T6 178-187 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T7 391-399 Disease denotes diarrhea http://purl.obolibrary.org/obo/MONDO_0001673
T8 666-674 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 727-745 Disease denotes sickle cell anemia http://purl.obolibrary.org/obo/MONDO_0011382
T10 739-745 Disease denotes anemia http://purl.obolibrary.org/obo/MONDO_0002280
T11 973-998 Disease denotes Graft‐versus‐host disease http://purl.obolibrary.org/obo/MONDO_0013730
T12 1131-1141 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T13 1321-1330 Disease denotes mucositis http://purl.obolibrary.org/obo/MONDO_0000888|http://purl.obolibrary.org/obo/MONDO_0020579
T15 1358-1372 Disease denotes herpes simplex http://purl.obolibrary.org/obo/MONDO_0004609
T16 1525-1536 Disease denotes neutropenia http://purl.obolibrary.org/obo/MONDO_0001475
T17 1797-1806 Disease denotes mucositis http://purl.obolibrary.org/obo/MONDO_0000888|http://purl.obolibrary.org/obo/MONDO_0020579
T19 1951-1963 Disease denotes facial palsy http://purl.obolibrary.org/obo/MONDO_0001835|http://purl.obolibrary.org/obo/MONDO_0005665
T21 1958-1963 Disease denotes palsy http://purl.obolibrary.org/obo/MONDO_0006496
T22 2497-2505 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T23 2510-2514 Disease denotes PRES http://purl.obolibrary.org/obo/MONDO_0044033
T24 2854-2863 Disease denotes varicella http://purl.obolibrary.org/obo/MONDO_0005700
T25 2910-2914 Disease denotes HHV8 http://purl.obolibrary.org/obo/MONDO_0005055
T26 3227-3230 Disease denotes TSE http://purl.obolibrary.org/obo/MONDO_0018926
T27 3772-3780 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 3782-3786 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T29 3952-3987 Disease denotes Acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T30 3958-3987 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T31 4417-4431 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T32 4457-4461 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T33 4512-4519 Disease denotes COVID19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 4699-4705 Disease denotes ataxia http://purl.obolibrary.org/obo/MONDO_0000437
T35 4767-4784 Disease denotes vision impairment http://purl.obolibrary.org/obo/MONDO_0001941
T36 4931-4955 Disease denotes Guillain‐Barré syndromes http://purl.obolibrary.org/obo/MONDO_0016218
T37 4957-4960 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T38 4997-5005 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T39 5154-5157 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T40 5176-5184 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 5260-5268 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T42 5358-5372 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T43 5579-5582 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T44 5731-5745 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T45 5811-5829 Disease denotes sickle cell anemia http://purl.obolibrary.org/obo/MONDO_0011382
T46 5823-5829 Disease denotes anemia http://purl.obolibrary.org/obo/MONDO_0002280
T47 5840-5850 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T48 5896-5900 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T49 5935-5949 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T50 6075-6083 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T51 6139-6160 Disease denotes peripheral neuropathy http://purl.obolibrary.org/obo/MONDO_0003620|http://purl.obolibrary.org/obo/MONDO_0005244
T53 6177-6180 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T54 6227-6231 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T55 6238-6247 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T56 6667-6676 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T57 6682-6686 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T3 51-54 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T4 62-63 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 616-617 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 678-681 http://purl.obolibrary.org/obo/CLO_0001602 denotes a 6
T7 678-681 http://purl.obolibrary.org/obo/CLO_0001603 denotes a 6
T8 678-681 http://purl.obolibrary.org/obo/CLO_0050248 denotes a 6
T9 678-681 http://purl.obolibrary.org/obo/CLO_0052463 denotes a 6
T10 734-738 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T11 812-821 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cell
T12 850-851 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 1050-1051 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T14 1230-1235 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T15 1373-1378 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T16 2126-2132 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T17 2170-2174 http://www.ebi.ac.uk/efo/EFO_0000876 denotes limb
T18 2257-2258 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T19 2306-2308 http://purl.obolibrary.org/obo/CLO_0050160 denotes T2
T20 2386-2392 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T21 2425-2430 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T22 2589-2591 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T23 2711-2722 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood cells
T24 2883-2888 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T25 2984-2985 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T26 3019-3021 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T27 3183-3188 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain
T28 3183-3188 http://www.ebi.ac.uk/efo/EFO_0000302 denotes brain
T29 3253-3259 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T30 3344-3349 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T31 3410-3416 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T32 3487-3489 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T33 3695-3700 http://www.ebi.ac.uk/efo/EFO_0000965 denotes Chest
T34 3865-3870 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T35 3865-3870 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T36 4186-4187 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T37 4247-4249 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T38 4407-4408 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T39 4435-4436 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T40 4552-4554 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T41 4565-4566 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 4642-4643 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T43 4721-4722 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T44 4893-4909 http://purl.obolibrary.org/obo/UBERON_0001021 denotes peripheral nerve
T45 5113-5114 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 5211-5212 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T47 5296-5322 http://purl.obolibrary.org/obo/UBERON_0000010 denotes peripheral nervous systems
T48 5296-5322 http://www.ebi.ac.uk/efo/EFO_0000891 denotes peripheral nervous systems
T49 5471-5477 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T50 5558-5559 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T51 5599-5600 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T52 5765-5766 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T53 5818-5822 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T54 6023-6039 http://purl.obolibrary.org/obo/UBERON_0001021 denotes peripheral nerve
T55 6306-6311 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T56 6341-6342 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 6368-6373 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 868-873 Chemical denotes donor http://purl.obolibrary.org/obo/CHEBI_17891
T2 912-920 Chemical denotes busulfan http://purl.obolibrary.org/obo/CHEBI_28901
T3 922-938 Chemical denotes cyclophosphamide http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027
T5 1036-1048 Chemical denotes methotrexate http://purl.obolibrary.org/obo/CHEBI_44185|http://purl.obolibrary.org/obo/CHEBI_50681
T7 1294-1303 Chemical denotes rituximab http://purl.obolibrary.org/obo/CHEBI_64357
T8 1484-1493 Chemical denotes acyclovir http://purl.obolibrary.org/obo/CHEBI_2453
T9 1631-1642 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T10 1644-1656 Chemical denotes piperacillin http://purl.obolibrary.org/obo/CHEBI_8232
T11 1657-1667 Chemical denotes tazobactam http://purl.obolibrary.org/obo/CHEBI_9421
T12 1686-1697 Chemical denotes vancomycine http://purl.obolibrary.org/obo/CHEBI_28001
T13 1716-1729 Chemical denotes ciprofloxacin http://purl.obolibrary.org/obo/CHEBI_100241
T14 1827-1838 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T15 1857-1866 Chemical denotes acyclovir http://purl.obolibrary.org/obo/CHEBI_2453
T16 2306-2308 Chemical denotes T2 http://purl.obolibrary.org/obo/CHEBI_29298|http://purl.obolibrary.org/obo/CHEBI_75710
T18 2440-2450 Chemical denotes gadolinium http://purl.obolibrary.org/obo/CHEBI_33375
T19 2633-2640 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T20 2687-2694 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T22 2969-2982 Chemical denotes nucleic acids http://purl.obolibrary.org/obo/CHEBI_33696
T23 2977-2982 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T24 3088-3095 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T25 3277-3287 Chemical denotes gadolinium http://purl.obolibrary.org/obo/CHEBI_33375
T26 4153-4164 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
19 195-203 Species denotes children Tax:9606
20 485-493 Species denotes children Tax:9606
21 572-583 Species denotes coronavirus Tax:11118
22 15-39 Disease denotes Coronavirus disease 2019 MESH:C000657245
23 41-49 Disease denotes COVID‐19 MESH:C000657245
24 121-141 Disease denotes respiratory distress MESH:D012128
25 172-187 Disease denotes viral pneumonia
26 323-328 Disease denotes fever MESH:D005334
27 330-339 Disease denotes tachypnea MESH:D059246
28 352-357 Disease denotes cough MESH:D003371
29 374-380 Disease denotes nausea MESH:D009325
30 381-389 Disease denotes vomiting MESH:D014839
31 391-399 Disease denotes diarrhea MESH:D003967
32 404-412 Disease denotes asthenia MESH:D001247
33 425-446 Disease denotes neurological symptoms MESH:D009422
44 691-698 Species denotes patient Tax:9606
45 704-711 Species denotes patient Tax:9606
46 912-920 Chemical denotes busulfan MESH:D002066
47 922-938 Chemical denotes cyclophosphamide MESH:D003520
48 1020-1031 Chemical denotes cyclosporin MESH:D016572
49 1036-1048 Chemical denotes methotrexate MESH:D008727
50 666-674 Disease denotes COVID‐19 MESH:C000657245
51 739-745 Disease denotes anemia MESH:D000740
52 761-782 Disease denotes cerebral vasculopathy MESH:C566007
53 973-998 Disease denotes Graft‐versus‐host disease MESH:D006086
57 1217-1235 Species denotes Epstein‐Barr virus Tax:10376
58 1237-1240 Species denotes EBV Tax:10376
59 1294-1303 Chemical denotes rituximab MESH:D000069283
64 1358-1380 Species denotes herpes simplex virus‐1 Tax:10298
65 1382-1387 Species denotes HSV‐1 Tax:10298
66 1484-1493 Chemical denotes acyclovir MESH:D000212
67 1321-1330 Disease denotes mucositis MESH:D052016
73 1544-1549 Species denotes HSV‐1 Tax:10298
74 1644-1667 Chemical denotes piperacillin‐tazobactam MESH:D000077725
75 1686-1697 Chemical denotes vancomycine MESH:D014640
76 1716-1729 Chemical denotes ciprofloxacin MESH:D002939
77 1512-1536 Disease denotes long febrile neutropenia MESH:D009503
79 1131-1155 Disease denotes infectious complications MESH:D011251
82 1857-1866 Chemical denotes acyclovir MESH:D000212
83 1797-1806 Disease denotes mucositis MESH:D052016
88 1918-1925 Species denotes patient Tax:9606
89 1941-1963 Disease denotes bilateral facial palsy MESH:D005158
90 1965-1993 Disease denotes left trigeminal hypoesthesia MESH:D006987
91 2170-2209 Disease denotes limb sensory‐motor deficit or areflexia MESH:D000071699
106 2725-2727 Gene denotes μL Gene:4591
107 3077-3095 Gene denotes C‐reactive protein Gene:1401
108 3097-3100 Gene denotes CRP Gene:1401
109 2749-2751 Gene denotes μL Gene:4591
110 2883-2888 Species denotes human Tax:9606
111 2889-2900 Species denotes Herpesvirus Tax:39059
112 2902-2908 Species denotes HHV) 6 Tax:10368
113 2910-2914 Species denotes HHV8 Tax:37296
114 2916-2926 Species denotes adenovirus Tax:10508
115 2878-2881 Species denotes EBV Tax:10376
116 2440-2450 Chemical denotes gadolinium MESH:D005682
117 2687-2694 Chemical denotes glucose MESH:D005947
118 2485-2495 Disease denotes hemorrhage MESH:D006470
119 2497-2505 Disease denotes ischemia MESH:D007511
121 3277-3287 Chemical denotes gadolinium MESH:D005682
133 3674-3677 Gene denotes CRP Gene:1401
134 3782-3792 Species denotes SARS‐CoV‐2 Tax:2697049
135 3920-3930 Species denotes adenovirus Tax:10508
136 3902-3905 Species denotes EBV Tax:10376
137 3518-3523 Disease denotes Fever MESH:D005334
138 3528-3548 Disease denotes respiratory symptoms MESH:D012818
139 3607-3628 Disease denotes neurological symptoms MESH:D009422
140 3646-3651 Disease denotes cough MESH:D003371
141 3656-3661 Disease denotes fever MESH:D005334
142 3772-3780 Disease denotes COVID‐19 MESH:C000657245
143 3952-3987 Disease denotes Acute respiratory distress syndrome MESH:D012128
148 4045-4052 Species denotes patient Tax:9606
149 4131-4141 Chemical denotes remdesevir
150 4153-4164 Chemical denotes tocilizumab MESH:C502936
151 4251-4266 Disease denotes Facial diplegia MESH:C531747
180 4437-4442 Species denotes child Tax:9606
181 4457-4467 Species denotes SARS‐CoV‐2 Tax:2697049
182 4593-4601 Species denotes patients Tax:9606
183 4854-4862 Species denotes patients Tax:9606
184 5201-5209 Species denotes children Tax:9606
185 5627-5634 Species denotes patient Tax:9606
186 5896-5906 Species denotes SARS‐CoV‐2 Tax:2697049
187 5852-5855 Species denotes EBV Tax:10376
188 4409-4431 Disease denotes cranial polyneuropathy MESH:D011115
189 4443-4451 Disease denotes infected MESH:D007239
190 4512-4519 Disease denotes COVID19 MESH:C000657245
191 4678-4687 Disease denotes dizziness MESH:D004244
192 4689-4697 Disease denotes headache MESH:D006261
193 4699-4705 Disease denotes ataxia MESH:D001259
194 4711-4718 Disease denotes seizure MESH:D012640
195 4767-4784 Disease denotes vision impairment MESH:D014786
196 4790-4806 Disease denotes neuropathic pain MESH:D009437
197 4816-4841 Disease denotes skeletal muscular failure MESH:D006333
198 4997-5005 Disease denotes COVID‐19 MESH:C000657245
199 5070-5096 Disease denotes facial paresia or diplegia MESH:C531747
200 5176-5184 Disease denotes COVID‐19 MESH:C000657245
201 5260-5268 Disease denotes COVID‐19 MESH:C000657245
202 5350-5372 Disease denotes cranial polyneuropathy MESH:D011115
203 5656-5677 Disease denotes cerebral vasculopathy MESH:C566007
204 5723-5745 Disease denotes cranial polyneuropathy MESH:D011115
205 5823-5829 Disease denotes anemia MESH:D000740
206 5831-5850 Disease denotes Viral co‐infections MESH:D001102
207 5935-5949 Disease denotes polyneuropathy MESH:D011115
213 6118-6126 Species denotes children Tax:9606
214 6469-6477 Species denotes patients Tax:9606
215 6075-6083 Disease denotes COVID‐19 MESH:C000657245
216 6139-6160 Disease denotes peripheral neuropathy MESH:D010523
217 6227-6247 Disease denotes SARS‐CoV‐2 infection MESH:C000657245

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T2 121-141 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T3 178-187 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T4 323-328 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T5 330-339 Phenotype denotes tachypnea http://purl.obolibrary.org/obo/HP_0002789
T6 341-357 Phenotype denotes productive cough http://purl.obolibrary.org/obo/HP_0031245
T7 374-389 Phenotype denotes nausea/vomiting http://purl.obolibrary.org/obo/HP_0002017
T8 391-399 Phenotype denotes diarrhea http://purl.obolibrary.org/obo/HP_0002014
T9 404-412 Phenotype denotes asthenia http://purl.obolibrary.org/obo/HP_0025406
T10 739-745 Phenotype denotes anemia http://purl.obolibrary.org/obo/HP_0001903
T11 1525-1536 Phenotype denotes neutropenia http://purl.obolibrary.org/obo/HP_0001875
T12 1941-1963 Phenotype denotes bilateral facial palsy http://purl.obolibrary.org/obo/HP_0430025
T13 1981-1993 Phenotype denotes hypoesthesia http://purl.obolibrary.org/obo/HP_0003474
T14 2200-2209 Phenotype denotes areflexia http://purl.obolibrary.org/obo/HP_0001284
T15 3518-3523 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T16 3635-3651 Phenotype denotes productive cough http://purl.obolibrary.org/obo/HP_0031245
T17 3656-3661 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T18 3958-3978 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T19 4251-4266 Phenotype denotes Facial diplegia http://purl.obolibrary.org/obo/HP_0001349
T20 4417-4431 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T21 4678-4687 Phenotype denotes dizziness http://purl.obolibrary.org/obo/HP_0002321
T22 4689-4697 Phenotype denotes headache http://purl.obolibrary.org/obo/HP_0002315
T23 4699-4705 Phenotype denotes ataxia http://purl.obolibrary.org/obo/HP_0001251
T24 4711-4718 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T25 4802-4806 Phenotype denotes pain http://purl.obolibrary.org/obo/HP_0012531
T26 4893-4916 Phenotype denotes peripheral nerve damage http://purl.obolibrary.org/obo/HP_0009830
T27 5358-5372 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T28 5731-5745 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T29 5823-5829 Phenotype denotes anemia http://purl.obolibrary.org/obo/HP_0001903
T30 5935-5949 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T31 6139-6160 Phenotype denotes peripheral neuropathy http://purl.obolibrary.org/obo/HP_0009830
T32 6360-6385 Phenotype denotes Cranial nerve involvement http://purl.obolibrary.org/obo/HP_0001291

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 528-535 http://purl.obolibrary.org/obo/GO_0009606 denotes tropism
T2 1419-1432 http://purl.obolibrary.org/obo/GO_0051179 denotes localizations
T3 3801-3814 http://purl.obolibrary.org/obo/GO_0003968 denotes transcriptase
T4 3801-3814 http://purl.obolibrary.org/obo/GO_0003899 denotes transcriptase
T5 4750-4755 http://purl.obolibrary.org/obo/GO_0050909 denotes taste
T6 4767-4773 http://purl.obolibrary.org/obo/GO_0007601 denotes vision
T7 5914-5926 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T8 6293-6311 http://purl.obolibrary.org/obo/GO_0009597 denotes detection of virus

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T3 0-14 Sentence denotes To the Editor:
T4 15-87 Sentence denotes Coronavirus disease 2019 (COVID‐19) has led to a pandemic in early 2020.
T5 88-188 Sentence denotes The typical clinical syndrome is respiratory distress, leading ultimately to severe viral pneumonia.
T6 189-259 Sentence denotes 1 In children, symptoms are reported to be milder compared to adults.
T7 260-413 Sentence denotes 2 , 3 In severely ill pediatric cases, the main symptoms are fever, tachypnea, productive cough, expectoration, nausea/vomiting, diarrhea and asthenia.
T8 414-591 Sentence denotes 4 Various neurological symptoms have also been reported in adults and children, consistent with the neurological tropism reported for certain members of the coronavirus family.
T9 592-598 Sentence denotes 5 , 6
T10 599-699 Sentence denotes We herein report a novel neurological presentation associated with COVID‐19 in a 6‐year‐old patient.
T11 700-783 Sentence denotes The patient presented with sickle cell anemia complicated by cerebral vasculopathy.
T12 784-972 Sentence denotes She underwent hematopoietic stem cell transplantation (HSCT) from a matched‐related donor following myeloablative conditioning (busulfan, cyclophosphamide, and anti‐T‐lymphocyte globulin).
T13 973-1049 Sentence denotes Graft‐versus‐host disease prophylaxis included cyclosporin and methotrexate.
T14 1050-1122 Sentence denotes A historical timeline is presented in the Supporting Information figure.
T15 1123-1203 Sentence denotes Various infectious complications occurred around the date of transplant (day 0):
T16 1204-1313 Sentence denotes Asymptomatic Epstein‐Barr virus (EBV) replication starting from day −14, treated with one rituximab infusion.
T17 1314-1494 Sentence denotes Severe mucositis, aggravated by concomitant herpes simplex virus‐1 (HSV‐1) reactivation (oral and pelvic localizations), early after conditioning, treated with high dose acyclovir.
T18 1495-1748 Sentence denotes Forty‐eight‐hour long febrile neutropenia during HSV‐1 reactivation, without other microbial documentation, treated with broad‐spectrum antibiotics (piperacillin‐tazobactam from day 0 to 20, vancomycine from day 2 to 15, ciprofloxacin from day 2 to 10).
T19 1749-1902 Sentence denotes At day 20, neutrophil engraftment was acheived, mucositis/HSV lesions healed, antibiotics were stopped, and acyclovir was switched to prophylactic doses.
T20 1903-2062 Sentence denotes At day 21, the patient presented with bilateral facial palsy, left trigeminal hypoesthesia, and voice alteration, followed 24 h later by swallowing impairment.
T21 2063-2210 Sentence denotes The full clinical picture was limited to impairment of cranial nerves V, VII, and IX, with no evidence for limb sensory‐motor deficit or areflexia.
T22 2211-2463 Sentence denotes Cerebral magnetic resonance imagery performed a few hours after onset of symptoms demonstrated T2‐FLAIR hypersignals of the intracranial and meatal segments of the two facial nerves as well as the left hypoglossal nerve, with T1 gadolinium enhancement.
T23 2464-2539 Sentence denotes There was no sign of hemorrhage, ischemia, or PRES syndrome (see Figure 1).
T24 2540-2753 Sentence denotes Cerebrospinal fluid (CSF) examination, performed 18 h after onset of symptoms , found normal protein level 25 mg/dL (reference range 15‐60 mg/dL), glucose 66 mg/dL, white blood cells 1/μL (reference range 0‐5/μL).
T25 2754-2983 Sentence denotes CSF Gram stain and culture were negative, as well as polymerase chain reaction (PCR) targeting HSV, varicella, enterovirus, EBV, human Herpesvirus (HHV) 6, HHV8, adenovirus, mycoplasma, Cryptococcus, and toxoplasma nucleic acids.
T26 2984-3076 Sentence denotes A second CSF examination performed 48 h after onset of symptoms was also found unconclusive.
T27 3077-3156 Sentence denotes C‐reactive protein (CRP) never exceeded 10 mg/L during this neurological phase.
T28 3157-3244 Sentence denotes FIGURE 1 Axial slices of brain magnetic resonance imagery (MRI) (T1w TSE SPIR images).
T29 3245-3517 Sentence denotes Cranial nerves enhancement upon gadolinium injection is shown: blue arrow pointing the hypoglossal nerve (left panel) and the two red arrows pointing the two facial nerves (right panel) Intravenous immunoglobulin (1 g/kg) was infused at days 22 and 23 without improvement.
T30 3518-3673 Sentence denotes Fever and respiratory symptoms appeared secondarily at day 25, 4 days after the onset of neurological symptoms, with productive cough and fever up to 40°C.
T31 3674-3694 Sentence denotes CRP remained normal.
T32 3695-3781 Sentence denotes Chest computerized tomography scan showed images characteristic of pulmonary COVID‐19.
T33 3782-3883 Sentence denotes SARS‐CoV‐2 reverse transcriptase‐PCR assay was positive in nasopharyngeal swab and blood, not in CSF.
T34 3884-3951 Sentence denotes No replication of EBV, HSV, CMV, or adenovirus could be documented.
T35 3952-4040 Sentence denotes Acute respiratory distress syndrome led to transfer to an intensive care unit at day 29.
T36 4041-4250 Sentence denotes The patient required protective mechanical ventilation for 17 days, received treatment by remdesevir (10 days), tocilizumab (two infusions), and a second course of intravenous immunoglobulin at days 51 and 52.
T37 4251-4312 Sentence denotes Facial diplegia was persistent beyond mechanical ventilation.
T38 4313-4368 Sentence denotes Significant clinical improvement started around day 60.
T39 4369-4468 Sentence denotes This case is the first description of a cranial polyneuropathy in a child infected with SARS‐CoV‐2.
T40 4469-4842 Sentence denotes Neurological symptoms during the course of COVID19 have been reported in more than 35% cases in a recent study of 214 adult patients, 7 with three possible presentations: (a) central manifestations including dizziness, headache, ataxia, and seizure, (b) peripheral symptoms, like taste, smell, or vision impairment, and neuropathic pain, and (c) skeletal muscular failure.
T41 4843-4917 Sentence denotes Of the 214 patients, only five presented isolated peripheral nerve damage.
T42 4918-5097 Sentence denotes Six cases of Guillain‐Barré syndromes (GBS) occurring 5‐10 days after onset of COVID‐19 were recently described in adults, four of them presenting with facial paresia or diplegia.
T43 5098-5194 Sentence denotes 8 One case of a 61‐year‐old was reported with complete GBS preceding typical COVID‐19 symptoms.
T44 5195-5373 Sentence denotes 9 In children, a recent study described neurological signs with COVID‐19 affecting both central and peripheral nervous systems, without reported forms of cranial polyneuropathy.
T45 5374-5583 Sentence denotes 10 Our observation is reminiscent of these reports, with some novel features: only craniofacial nerves were impaired, symptoms were presenting manifestations, and CSF never displayed a classic profile of GBS.
T46 5584-5830 Sentence denotes The context of a heavily immunocompromised patient and the pre‐existing cerebral vasculopathy may explain these discrepancies, even though cranial polyneuropathy is not reported as a classic side effect of HSCT conditioning or sickle cell anemia.
T47 5831-6007 Sentence denotes Viral co‐infections (EBV and HSV) may also have interplayed with SARS‐CoV‐2 in the pathogenesis of this polyneuropathy, although no concomitant replication could be documented.
T48 6008-6084 Sentence denotes In conclusion, peripheral nerve involvement is rarely described in COVID‐19.
T49 6085-6248 Sentence denotes The present report confirms that children can display peripheral neuropathy, reminiscent of GBS or Miller‐Fischer syndromes, with concomitant SARS‐CoV‐2 infection.
T50 6249-6359 Sentence denotes Neurological symptoms may precede or follow detection of virus replication, as described in a few adult cases.
T51 6360-6478 Sentence denotes Cranial nerve involvement might predict an aggressive course of the disease, especially in immunocompromised patients.
T52 6480-6500 Sentence denotes CONFLICT OF INTEREST
T53 6501-6565 Sentence denotes The other authors declare that there is no conflict of interest.
T54 6567-6589 Sentence denotes Supporting information
T55 6590-6611 Sentence denotes Supplementary Figure:
T56 6612-6692 Sentence denotes Timeline of the medical events preceding and following infection with SARS‐CoV‐2
T57 6693-6729 Sentence denotes Click here for additional data file.